STAT+: ViiV expands licensing deal for its HIV drug in low-income countries
STAT
JULY 15, 2025
Once again, ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism. Under the latest arrangement , the company is expanding a licensing agreement reached three years ago with the Medicines Patent Pool, which is backed by the United Nations and negotiates licensing rights for manufacturing to generic companies.
Let's personalize your content